Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy — Riccardo Giossi (2024) | RDL Network
Unprescribed cannabis use is common in patients with MS in Italy, with observed prevalence seemingly superior to the general population, often intended for medical use and without the disclosure to the treating physician, although with potential clinical benefits.
Riccardo Giossi, Martina Mercenari, Massimo Filippi, Chiara Zanetta, Carlo Antozzi, Laura Brambilla, Paolo Confalonieri, Sebastiano Giuseppe Crisafulli, Eugenia Tomás Roldán, Pietro Annovazzi, Marta Zaffira Conti, Caterina Barrilà, Marco Ronzoni, Monica Grobberio, Attilio Negri, Stefan Gustavsen, Valentina Torri Clerici
Ruth Ann Marrie, John D. Fisk, Randy Walld, James M. Bolton, Jitender Sareen, Scott Burton Patten, Alexander Singer, Lisa M. Lix, Carol Hitchon, Renée El‐Gabalawy, Alan Katz, James Marriott, Çharles N. Bernstein
Discussion(0)
No comments yet. Be the first to comment.